glutathione disease Controlling entry into mitochondria: potential roles for SLC25A39 in health and (treatment of) Glutathione dysregulation and the etiology
Description
[DOI] [PMC free article] [PubMed] 165.Geier DA, Kern JK, Geier MR
It potentially reduces inflammation by increasing microRNA-146a expression, thereby decreasing pro-inflammatory cytokines IRAK1 and TRAF6 [27]
Octreotide is clinically ineffective in this context (135), but may be effective if glucocorticoids are lowered
However, more recent evidence suggests that sustained supplementation at moderate doses may modestly raise levels over time
A great choice for clients who want consistent, natural feeling vitality
